60
Participants
Start Date
June 22, 2024
Primary Completion Date
November 22, 2024
Study Completion Date
December 1, 2024
Dexmedetomidine Group / Group D
In this study, the intervention involve administrating 0.5 mcg/kg of Inj dexmedetomidine intravenously over 10 min to patients in intervention group/group D 2 minutes prior to Endotracheal intubation using laryngoscopy aiming to asses its efficacy in attenuating the pressor response to laryngoscopy.
Normal Saline (Placebo)
The Placebo group / group C will be administer Normal Saline without any active medication over 10 min to patients, 2 minutes prior to Endotracheal intubation using laryngoscopy to compare its effect to those of Dexmedetomidine in attenuating the pressor response to laryngoscopy.
RECRUITING
Liaquat National Hospital and Medical College, Karachi
Liaquat National Hospital & Medical College
OTHER